CLDI
Calidi Biotherapeutics, Inc. (CLDI) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
CLDI shows limited disclosed environmental intensity data, which constrains peer comparison and leaves its operational footprint less transparent than better-reporting peers.
Zero reported R&D-to-revenue suggests a lighter innovation spend profile, but it does not by itself indicate stronger environmental management versus peers.
The provided metrics do not evidence elevated leverage-driven environmental risk, yet they also do not show a structural sustainability advantage over peers.
Absent disclosed emissions, energy, or waste metrics, CLDI appears broadly average on environmental transparency relative to peers, with no clear leading indicators.
Social
No disclosed workforce, safety, or human-capital metrics are provided, limiting visibility into CLDI’s social practices versus more transparent peers.
Zero stock-based compensation-to-revenue suggests lower equity-linked pay intensity, but it does not establish stronger employee alignment or retention than peers.
The lack of reported social indicators increases reputational uncertainty, because stakeholders cannot compare CLDI’s labor and community practices with peer disclosures.
On the available data, CLDI appears neither clearly advantaged nor clearly impaired socially relative to peers, but disclosure depth remains thin.
Governance
Debt-to-equity of 0.62 and net debt-to-EBITDA of 0.13 indicate restrained balance-sheet leverage, which generally supports governance discipline versus more levered peers.
Zero stock-based compensation-to-revenue suggests limited dilution pressure, but it also leaves less evidence of incentive structures that align management with shareholders.
The absence of disclosed governance controversies in the provided data avoids a peer-relative penalty, yet it does not demonstrate best-in-class oversight.
Overall governance appears modestly better than average on capital discipline, but limited disclosure prevents a stronger relative ESG assessment.
Overall Score
CLDI’s ESG positioning is broadly average versus peers, with modest governance discipline offset by limited disclosure across environmental and social dimensions.
Score Driver: Limited ESG Disclosure Depth Relative To Peers
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Calidi Biotherapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
